The Section of Pulmonary, Critical Care, and Sleep Medicine at Baylor College of Medicine is nationally recognized for its excellence in healthcare, research and education.

The section has total research support of $4.8 million from federal and private research grants including lung cancer, asthma, COPD, pulmonary hypertension, pulmonary fibrosis, transitional medicine, lung transplant, and cystic fibrosis.

Many physicians from the section are national and international experts. Together, they offer an incredibly large array of services, from general pulmonary and sleep medicine to highly specialized advanced lung diseases, such as including pulmonary hypertension, pulmonary fibrosis, adult cystic fibrosis, COPD/asthma, interstitial lung disease, lung and heart-lung transplantation, critical care, and interventional pulmonology.

The section offers four fellowship programs, including Pulmonary & Critical Care, Critical Care Medicine, Lung Transplantation, and Sleep Medicine. Many alumni and former fellows can be found in academic, research and healthcare leadership roles.

News

Baylor faculty honored for excellence in teaching, educationToday
Baylor College of Medicine faculty members selected as outstanding educators for 2016 were honored at the Medical Education Awards Ceremony.
Decrease your chances of developing skin cancerToday
A Baylor College of Medicine skin expert reminds us that no tan is a healthy tan but instead increases the risk of developing skin cancer.
Dan L Duncan Comprehensive Cancer Center researchers awarded CPRIT grants to support the fight against cancerYesterday
Three researchers from the Dan L Duncan Comprehensive Cancer Center at Baylor have been awarded academic research program grants from the Cancer Prevention and Research Institute of Texas.
First large-scale proteogenomic study of breast cancer provides insight into potential therapeutic targetsYesterday
Researchers completed the first large-scale “proteogenomic” study of breast cancer, linking DNA mutations to protein signaling and helping pinpoint the genes that drive cancer.
Differences in metabolism between androgen-dependent and castration resistant prostate cancer may lead to new therapiesMay 19, 2016
Researchers have determined that castration resistant prostate cancer has particular metabolic characteristics that may open new possibilities for treatment.